Cargando…

Phenotypic Profiling of Immune Cells and Their Mediators in Chronic Obstructive Pulmonary Disease

Background: Chronic obstructive pulmonary disease (COPD) is an inflammatory disorder and has been proposed to have an imbalance between pro-inflammatory and anti-inflammatory factors. Methods: This study was conducted on 41 participants {18 COPD patients (smokers, COPD S (n = 9); reformed smokers, C...

Descripción completa

Detalles Bibliográficos
Autores principales: Sampath, Meghashree, Bade, Geetanjali, Guleria, Randeep, Mohan, Anant, Sen, Sudip, Dey, Devanjan, Talwar, Anjana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452296/
https://www.ncbi.nlm.nih.gov/pubmed/37626663
http://dx.doi.org/10.3390/biomedicines11082166
_version_ 1785095633730797568
author Sampath, Meghashree
Bade, Geetanjali
Guleria, Randeep
Mohan, Anant
Sen, Sudip
Dey, Devanjan
Talwar, Anjana
author_facet Sampath, Meghashree
Bade, Geetanjali
Guleria, Randeep
Mohan, Anant
Sen, Sudip
Dey, Devanjan
Talwar, Anjana
author_sort Sampath, Meghashree
collection PubMed
description Background: Chronic obstructive pulmonary disease (COPD) is an inflammatory disorder and has been proposed to have an imbalance between pro-inflammatory and anti-inflammatory factors. Methods: This study was conducted on 41 participants {18 COPD patients (smokers, COPD S (n = 9); reformed smokers, COPD RS (n = 9)) and 23 controls (non-smokers, CNS (n = 14); smokers, CS (n = 9))}. Flow cytometry was used to identify circulatory immune cells and correlated with serum cytokines. Results: On comparison, significantly lower frequency of CD3+ T cells were observed in COPD S as compared to CNS (p < 0.01) and CS (p < 0.01); CD4+ T cells were lower in COPD S (p < 0.05), COPD RS (p < 0.05) and CNS (p < 0.01) as compared to CS. CD8+ T cells were elevated in COPD S as compared to CS (p < 0.05). Lower frequency of cDCs were observed in COPD S as compared to CS (p < 0.05) and COPD RS as compared to CNS (p < 0.01) and CS (p < 0.01). Lower frequency of pDCs were observed in COPD RS as compared to COPD S (p < 0.05), CNS (p < 0.05) and CS (p < 0.01). Lower frequency of Tregs was observed in COPD S as compared to CNS (p < 0.05) and CS (p < 0.05). Conclusions: Characteristic changes observed indicate a significant impact of immune cells in the progression of the disease.
format Online
Article
Text
id pubmed-10452296
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-104522962023-08-26 Phenotypic Profiling of Immune Cells and Their Mediators in Chronic Obstructive Pulmonary Disease Sampath, Meghashree Bade, Geetanjali Guleria, Randeep Mohan, Anant Sen, Sudip Dey, Devanjan Talwar, Anjana Biomedicines Article Background: Chronic obstructive pulmonary disease (COPD) is an inflammatory disorder and has been proposed to have an imbalance between pro-inflammatory and anti-inflammatory factors. Methods: This study was conducted on 41 participants {18 COPD patients (smokers, COPD S (n = 9); reformed smokers, COPD RS (n = 9)) and 23 controls (non-smokers, CNS (n = 14); smokers, CS (n = 9))}. Flow cytometry was used to identify circulatory immune cells and correlated with serum cytokines. Results: On comparison, significantly lower frequency of CD3+ T cells were observed in COPD S as compared to CNS (p < 0.01) and CS (p < 0.01); CD4+ T cells were lower in COPD S (p < 0.05), COPD RS (p < 0.05) and CNS (p < 0.01) as compared to CS. CD8+ T cells were elevated in COPD S as compared to CS (p < 0.05). Lower frequency of cDCs were observed in COPD S as compared to CS (p < 0.05) and COPD RS as compared to CNS (p < 0.01) and CS (p < 0.01). Lower frequency of pDCs were observed in COPD RS as compared to COPD S (p < 0.05), CNS (p < 0.05) and CS (p < 0.01). Lower frequency of Tregs was observed in COPD S as compared to CNS (p < 0.05) and CS (p < 0.05). Conclusions: Characteristic changes observed indicate a significant impact of immune cells in the progression of the disease. MDPI 2023-08-01 /pmc/articles/PMC10452296/ /pubmed/37626663 http://dx.doi.org/10.3390/biomedicines11082166 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Sampath, Meghashree
Bade, Geetanjali
Guleria, Randeep
Mohan, Anant
Sen, Sudip
Dey, Devanjan
Talwar, Anjana
Phenotypic Profiling of Immune Cells and Their Mediators in Chronic Obstructive Pulmonary Disease
title Phenotypic Profiling of Immune Cells and Their Mediators in Chronic Obstructive Pulmonary Disease
title_full Phenotypic Profiling of Immune Cells and Their Mediators in Chronic Obstructive Pulmonary Disease
title_fullStr Phenotypic Profiling of Immune Cells and Their Mediators in Chronic Obstructive Pulmonary Disease
title_full_unstemmed Phenotypic Profiling of Immune Cells and Their Mediators in Chronic Obstructive Pulmonary Disease
title_short Phenotypic Profiling of Immune Cells and Their Mediators in Chronic Obstructive Pulmonary Disease
title_sort phenotypic profiling of immune cells and their mediators in chronic obstructive pulmonary disease
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452296/
https://www.ncbi.nlm.nih.gov/pubmed/37626663
http://dx.doi.org/10.3390/biomedicines11082166
work_keys_str_mv AT sampathmeghashree phenotypicprofilingofimmunecellsandtheirmediatorsinchronicobstructivepulmonarydisease
AT badegeetanjali phenotypicprofilingofimmunecellsandtheirmediatorsinchronicobstructivepulmonarydisease
AT guleriarandeep phenotypicprofilingofimmunecellsandtheirmediatorsinchronicobstructivepulmonarydisease
AT mohananant phenotypicprofilingofimmunecellsandtheirmediatorsinchronicobstructivepulmonarydisease
AT sensudip phenotypicprofilingofimmunecellsandtheirmediatorsinchronicobstructivepulmonarydisease
AT deydevanjan phenotypicprofilingofimmunecellsandtheirmediatorsinchronicobstructivepulmonarydisease
AT talwaranjana phenotypicprofilingofimmunecellsandtheirmediatorsinchronicobstructivepulmonarydisease